Volume 3, Issue 2 (2017)                   Pharm Biomed Res 2017, 3(2): 19-25 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghorbel I, Elwej A, Chaabane M, Jamoussi K, Zeghal N. Protective effect of selenium against aluminium chloride induced cardiotoxicity in rats. Pharm Biomed Res. 2017; 3 (2) :19-25
URL: http://pbr.mazums.ac.ir/article-1-165-en.html
1- Animal Physiology Laboratory, Sciences Faculty of Sfax. University of Sfax, BP 1171, 3000 Sfax, Tunisia
2- Biochemistry Laboratory, CHU Hedi Chaker, University of Sfax, 3029 Sfax, Tunisia
Abstract:   (3732 Views)
Our study pertains to evaluate the protective effect of selenium (Se), used as a nutritional supplement, against aluminium chloride induced cardiotoxicity in rats. Rats have received during 21 days either AlCl3 (400 ppm) via drinking water, AlCl3 associated with Na2SeO3 (0.5 mg/kg of diet) or only Na2SeO3. Co-administration of Se to AlCl3 treated rats alleviated heart oxidative stress objectified by a decrease of malondialdehyde, hydrogen peroxide and protein carbonyls levels. An improvement in antioxidant redox status, enzymatic (catalase, superoxide dismutase and glutathione peroxidase) and non enzymatic (reduced glutathione, non protein thiols and vitamin C) was also observed in Se treated rats.  LDH and CK activities, TC, LDL-C levels, TC/HDL-C and LDL-C/HDL-C ratios were increased, while HDL-C and TG decreased in rats treated with AlCl3. Cardiac biomarkers and lipid profile were restored to near control values by the supplementation of Se. Our results revealed that Se, a trace element with antioxidant properties, was effective in preventing heart damage induced by aluminium chloride.
Full-Text [PDF 581 kb]   (1931 Downloads)    
Type of Study: Original Research | Subject: Pharmacology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb